The fund is a LOF of the CSI Precision Medical Index. The fund manager is Lin Zhiming. The fund mainly invests in the stocks of listed companies in the precision medicine field, with an investment ratio of not less than 80% of the fund assets. The risk and return characteristics of this fund are high risk and high return.
Huitianfu Fund Management Co., Ltd. manages the Huitianfu CSI Precision Medical Theme Index Fund (LOF), a stock fund whose contract took effect on January 21, 2016. The fund is registered with the China Securities Regulatory Commission and tracks its target index, so it has risk and return characteristics similar to that index.
The fund is described as having higher expected risk and return than mixed, bond, and money market funds. A single investor other than the initiator may not hold 50% or more of the total fund shares, and the summary's financial data are as of June 30, 2018 and unaudited. This manual is written in Chinese.
| Fund type | Stock fund |
|---|---|
| Risk/return profile | Higher risk and higher expected return than mixed, bond, and money market funds |
| Index tracking | Tracks the target index with similar risk/return characteristics |
| Single-investor holding limit | May not reach or exceed 50% of total fund shares |
| Fund contract effective date | January 21, 2016 |
| Registration | Registered with CSRC under permission [2015] No. 2740 |
| Manager established | February 3, 2005 |
| Registered capital | RMB 132,724,224 |
It is a stock fund with higher expected risk and return than mixed, bond, and money market funds.
Yes, as an index fund it tracks the target index and has similar risk and return characteristics.
A single investor, other than the initiator, may not hold 50% or more of the total fund shares.
The fund contract took effect on January 21, 2016.